Home / Stocks / LGND

LGND insider trading

LIGAND PHARMACEUTICALS INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$1.2M
Buys · last 90 days
0 · $0
Most recent buy
2025-05-13

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-14Espinoza Octavio
Chief Financial Officer
Sold31,641$292.06$9.2M
2026-08-14Haas Jason
Director
Sold7,138$292.81$2.1M
2026-06-12Aryeh Jason
Director
Sold4,500$250.00$1.1M
2025-05-13Davis Todd C
Chief Executive Officer
Bought9,510$105.20$1.0M
2025-05-13Espinoza Octavio
Chief Financial Officer
Bought1,500$104.06$156k

Most active insider buyers

InsiderRoleBuysTotal bought
Davis Todd CChief Executive Officer1$1.0M
Espinoza OctavioChief Financial Officer1$156k

See LGND on the chart

Every insider buy and sell for LGND plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.